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Abstract
Our main tenet argues that the primary role of positive thymic selec-
tion and the resulting T cell population is the maintenance of a homeo-
static equilibrium with self MHC-self peptide complexes. The homeostatic
T cell repertoire can recognize infections non-specifically and this is an
indirect (negative) recognition: the whole homeostatic T cell population
together “holds a mirror” to the whole self, and any MHC-peptide com-
plex that is “not reflected in the mirror” can be perceived by surrounding
homeostatic T cells as a signal of the presence of a foreign entity. On the
other hand, infection-specific T cell clones arise in a different pathway in
the periphery, do not enter the thymus, and form a functionally different
population. Here we summarize the basic assumptions and consequences
of a logic-based new model, which differs from conventional models in
many respects.
Keywords: T lymphocyte system; Positive thymic selection; Homeostatic
control; Indirect recognition
1 Introduction
1.1 Fundamentals.
The aim of this work is to describe a logic-based model of the fundamental
operation of the T lymphocyte system. This means that the resulting model is
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obtained by a chain of logical arguments, though we are able to cite several sup-
porting experimental references as well. We hope that our theoretical model can
constitute a logically consistent basis to in silico experiments with the immune
system and can lead to new therapies as well.
Let us begin with some basic, more-or-less generally accepted assumptions,
or even experimentally established facts, about the human immune system that
we need in this paper[1, 2]. Normally, each human cell carries a large variety of
different MHC I molecules on its surface. Their function is to present peptide
fragments of inner proteins to the surveillance of the cytotoxic (CD8+) T cell
repertoire, which is a major constituent of the adaptive immune system. Ideally,
the set of MHC I-peptide complexes on the surface of a cell represents accurately
the inner metabolism of the cell, and, based on this information, the CD8+ T
cell repertoire is able to decide if there is a harmful entity inside or not.
The average length of a peptide attached to an MHC is about 10 aminoacids,
so there can potentially exist about 2010 ≈ 1013 different peptides. On the other
hand, there can exist of the order of 106 (≈ no. of different proteins × average
length of a protein / average length of a peptide) possible different self peptides,
which is obviously a tiny fraction of the potential variation. The number of
different T cell clones at any moment is of the order of 106 as well, so the T cell
repertoire should be carefully developed.
Thymus forms early in the embryonic development. Its main function is to
develop and select a suitable T cell repertoire from the ones randomly generated
in the bone marrow. T cells with strongly self-reactive receptors should be
eliminated to prevent autoimmune reactions: this is called negative selection. It
is much less obvious what positive selection may mean. Since genes encoding
MHC proteins are highly polymorphic, there exists a large variation of individual
MHC proteins. Thus, it is clear that one function of the positive selection must
be to select T cells that are able to recognize self MHC molecules.
1.2 What is the problem with conventional models of the
T cell system?
Standard textbooks in immunology teach that the role of positive selection is to
identify and preserve T cells that are likely to be able to respond to complexes
of self MHC and foreign peptides; those that do not pass this test die due
to neglect [1, 2]. A natural doubt may arise then: How can the thymus of a
fetus learn what would constitute a suitable T cell repertoire to fight against
an unknown universe of harmful agents, whose size is several magnitude larger
than the actual T cell repertoire of the fetus? How could the thymus biologically
represent agents that the fetus has never met? Since the choice of the foreign
peptide repertoire should be very carefully made, what inner force would make
the choice and how?
On the other hand, even standard textbooks [1] (Section III 7 Summary)
mention that recognition of self MHC-self peptide complexes on thymic epithe-
lial cells provides a positive survival signal for developing T cells. It is referred
to as “one of the central mysteries of immunology”.
Positive thymic selection has recently obtained much attention in the liter-
ature, cf. e.g. [3, 4, 5, 6, 7]. It has become clear that T cells emerging from
the thymus must react with some self peptide-self MHC complex with not too
strong affinity. One major consequence of medium self reactivity must be that
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thymus selected T cells create a homeostatic equilibrium with self cells in the
periphery.
In the last decade there has been a growing number of evidence challenging
the conventional view of thymus selected T cells, and emphasizing the homeo-
static role of the T cell system, cf. e.g. [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18].
Our research group also described some of the ideas of a homeostatic model in
earlier papers [19, 20, 21], where the reader can find more biological background
as well. In the last cited paper we introduced the expression “homeostatic role
of T cells model”, or “HRT model” for short, to refer to our approach.
We claim that if someone accepts that during embryonic development the
immune system of the fetus can only learn what constitutes his/her own self, and
essentially nothing about future potentially harmful invaders, then practically
every assumption in this paper describing how the T cell system functions follows
by logical necessity.
2 Main Assumptions of a New Model
2.1 Positive selection in the thymus is based on self MHC-
self peptide complexes.
Our main tenet argues that during embryonic development thymus forms to
carry a nearly complete repertoire of all self MHC-self peptide complexes that
can be found in the fetus. In essence, the immune system of the fetus learns
what constitutes self. Negative selection eliminates dangerous T lymphocytes
that can bind too strongly to any self MHC-self peptide complexes and may
cause autoimmunity. Positive selection supports T cells that can bind to some
self MHC-self peptide complex with a medium, standardized affinity. In this
respect, the thymus works as a filter, letting only standardized T cells out.
Fig. 1 shows a simplified graphical comparison between the new and the
conventional models. Assume that the shape of a T cell receptor (TCR) is rep-
resented by a point of a so-called shape space. For visualization purposes, it
can be assumed that the space of shapes and other chemical and physical prop-
erties relevant for binding between a ligand and a receptor can be represented
by a large region in the plane. Only complementary or nearly complementary
shaped ligands and receptors can bind. Similarity of shapes corresponds to
metric distance in our simplified scheme; that is, the affinity depends on the
distance of the corresponding points in the shape space. The figure shows a
tiny subrectangle of the shape space. The dots in the figure represent TCR’s
that are exactly complementary to some self MHC-self peptide complex. The
areas shaded in gray represent the set of shapes that are allocated to possible
TCR’s after negative and positive selection in the two respective models.
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New model Conventional models
Fig. 1. Graphical representation of the difference between the new homeostatic and
the conventional models
The figure shows that according to conventional models a large and suppos-
edly unknown gray region should be covered by the T cell repertoire by birth.
In that model the gray region is the set of all possible TCR shapes excluding
the complementary neighborhoods of self MHC-self peptide complexes.
On the other hand, according to our new model much smaller gray rings
show possible positions of the elements of the T cell repertoire: ideally, at least
one T cell clone (one kind of TCR) is centered in each gray ring. Moreover, these
gray rings can be completely known and represented by the thymus by the time
of birth, since they are uniquely determined by the self cells. This means that
in our model the T cell repertoire of a fetus (that has not met infection yet)
consists of T cells that are able to bind some self MHC-self peptide complex
with medium avidity, but cannot bind any self MHC-self peptide as strongly as
to start a dangerous autoimmune reaction. That is why the grey rings of our
model cover the outer part of the white discs of a conventional model.
2.2 The thymus selected T cell repertoire has a homeo-
static role.
Accepting the fact that for the survival of a T cell clone it is necessary to have
a regular stimulus from binding MHC-peptide complexes [22, 23], it follows
that in a healthy state of the individual there must be a dynamic equilibrium
between the T cell repertoire and the repertoire of different MHC-self peptide
complexes. This results in a thymus-selected homeostatic T cell repertoire which
establishes a homeostatic control for both self cells and T cells. This control
sets upper and lower limits for the number of cells in each specific T cell clone
and also for the number of corresponding self cells at any given time. While
in normal, healthy circumstances tissues are not penetrable for T cells, they
are penetrable for TCR’s shed by T cells. Tissue cells also regularly shed their
MHC I-peptide complexes into the circulating lymph. Thus, extending the pre-
viously mentioned homeostatic network with soluble TCR’s and MHC-peptide
complexes, we assume that the body has a practically complete surveillance
system, which takes care of inner tissue cells as well and is in equilibrium in a
healthy individual.
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This homeostatic control can explain why the role of thymus decreases with
age, and negative and positive selection in the thymus is gradually replaced by
the homeostatic control of the periphery. In fact, a too weakly binding T cell
clone does not get suitable stimulus and “dies by neglect”; while a too strongly
binding T cell clone has not enough time to divide. Thus a medium avidity is
optimal for the survival of a T cell clone. This observation is consistent with
the molecular complementarity principle [24, 25].
2.3 Recognition of non-self entities or mutated self cells is
carried out by the whole homeostatic T cell repertoire.
In this section we only consider infections or mutations for which there exists no
immune memory; creation of infection-specific clones are discussed in Section 3.
In contrast to conventional models, one of our major tenets says that a
single T cell cannot and should not decide alone what is self and what is non-
self. Shapes of self and non-self entities are intricately interwoven sets; in the
language of the shape space model, the subsets of points representing self and
non-self are complexly interlaced and cannot be separated by a nice smooth
mathematical curve that even an individual T cell might “memorize”: the com-
plexity of the antigen universe exceeds the capacity of an individual T cell. The
“knowledge” of each specific T cell is represented by the shapes of its recep-
tors, especially by its TCR. This implies that the task an individual T cell can
carry out is to recognize complementary or near complementary MHC-peptide
complexes. This way a specific T cell clone is responsible for the population of
complementarily shaped specific self MHC-self peptide complexes in the body.
Only the whole thymus-selected T cell population is able to answer the
fundamental question of immune recognition, self/non-self discrimination. Al-
though homeostatic T cells act independently of each other, together they “hold
a mirror” to the whole self; their whole repertoire accurately reflects the whole
self antigen population, and this can be used to distinguish self and non-self
in the way described below. Briefly, a peptide belongs to non-self it is “not
reflected in the mirror”.
A tissue cell carries a large variety of different MHC I-peptide complexes.
If the cell is healthy, then each of these specific complexes are regularly bound
by their own specific complementary TCR’s circulating in the lymph in the
neighborhood of the cell. This is a vital feedback to the cell that its metabolism
works all right.
After a new viral infection or mutation affecting the cell’s metabolism, new
non-self or new mutated self peptides appear in some of its surface MHC I
molecules. We assume that the typical consequence of this is that for a critically
long period of time these MHC I-foreign peptide complexes are not bound by
any surrounding TCR’s. This way, the cell receives a vital signal from the whole
homeostatic T cell system: “something is wrong inside”. Again, by simple logic,
in this multiplayer game in the neighborhood of the infected cell the only entity
that can “know of” the presence of e.g. a viral invader is the infected cell itself,
after not getting a binding partner for some of its surface MHC I molecule for
a critically long period of time. Thus it is reasonable to assume that such an
infected cell becomes excited, ready to signal the problem to its environment.
One important aspect of our new homeostatic model is that the recognition
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of a dangerous new agent is an indirect (negative) recognition: the absence of
existing TCR partners signals the problem.
Other elements of the immune system, especially T cells, can get the infor-
mation that there is a problem in two ways. One way is that alarm signals,
that is, specific chemokines, are secreted by an infected cell into its environ-
ment. Their role will be explained in paragraph 2.5; however, there is another
pathway through lymph nodes as well, described in the next paragraph.
An important advantage of the non-specific, polyclonal reaction of the ready
and always present homeostatic T cell repertoire against a new foreign entity
is that they can react much faster than an infection-specific T cell clone of the
conventional models: the latter’s creation can last too long to stop e.g. a rapidly
replicating virus.
2.4 An alarm signal arises in a lymph node if there is an
invader in the periphery.
It is experimentally observed that somatic cells shed their MHC I-peptide com-
plexes into the lymph. Similarly as with the thymus, we assume that in a
healthy individual there exists a practically complete homeostatic repertoire of
CD8+ T cells and TCR molecules in a lymph node to capture almost all soluble
self MHC I-self peptide complexes. On the other hand, MHC I-foreign peptide
complexes cannot be captured by any TCR’s present in a lymph node, so the
concentration of the latter complexes will be larger at certain parts of the lymph
node, where they can be captured by dendritic APC’s. This filtering effect is a
kind of reverse of the filtering in the thymus: the thymus lets through T cells
that are able to interact with some self MHC-self peptide complexes (with stan-
dardized, medium strength affinity, cf. 2.1), while pathways in a lymph node
let through only those soluble MHC-peptide complexes that are foreign (not
complementary) to the homeostatic T cell repertoire.
In general, APC’s present peptide fragments of native proteins sampled from
the humoral phase to the surveillance of circulating helper (CD4+) T cells.
This presentation occurs on surface MHC II molecules of the APC’s. In a
healthy individual, a dendritic APC in a lymph node will present only self
peptide complexes on its MHC II molecules. This means that all of the MHC
II-peptide complexes of the dendritic cell will be regularly visited by specific
complementary cells of the homeostatic CD4+ T cell repertoire. However, after
infection or mutation, some of the surface MHC II molecules on some dendritic
cells will present foreign peptides. Consequently these new complexes will not
be bound by any member of the homeostatic helper T cell repertoire for a critical
period of time. This is a vital signal for a sentinel dendritic cell: it shows that
there is a problem somewhere in the periphery. Thus this dendritic cell gets
excited and releases alarm signals : specific interleukins to helper and cytotoxic
T cells in the lymph node. As a result, a non-specific, polyclonal reaction
follows: many of the T cells leave the lymph node to search for invaders in the
periphery. Again, it should be emphasized that – in contrast to conventional
models – not individual T cells, but only the whole homeostatic repertoire of
CD4+ T cells can recognize the presence of a foreign invader.
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2.5 CD8+ T cells find their targets in the periphery by
the help of alarm signals.
How can activated T cells find their targets in the periphery? As it was described
above, after a while infected or mutated tissue cells start secreting alarm signals,
that is, specific chemokines. These signals help cytotoxic T cells to penetrate
the corresponding tissue and to find their targets to destroy. We call this the
“smoking gun” phenomenon. We assume that such an alarm signal leads to a
non-specific, polyclonal immune answer from any CD8+ T cell getting close to
affected tissue cells, lysing infected cells, that is, cells that are in an excited
state. We refer to this phenomenon as physiological transplantation reaction.
In fact, the strong reaction of the T cell system against transplanted tissues
cannot be found under natural conditions, so it needs a physiological explana-
tion. Our model implies that this strong reaction is ignited by alarm signals
secreted by all excited cells in a transplanted tissue because they all are missing
their complementary TCR partners.
We mention that alarm signals in our model significantly differ from the
danger signals in Matzinger’s theory, where danger signals alert the immune
system to dying cells [26, 27].
The above described main assumptions can hopefully explain why we call
our model “homeostatic role of T cells model” (HRT model).
3 Infection-Specific T Cell Clones in the HRT
Model
It is important that our HRT model can and does accommodate infection-
specific T cell clones as well. The ideas described in Section 2 correspond to
the case when the immune system meets a new infecting agent; moreover, they
describe the behavior of the T cells in the initial phase of a new infection.
Immature T cells are constantly and randomly generated in the bone marrow
and they circulate before the thymus filters out the ones unsuitable for the
homeostatic surveillance. If a new infection persists for several days, then a few
specific T cells may randomly be generated with high affinity to peptides of the
infection presented by MHC’s. By chance, even a thymus-standardized T cell
can have high affinity to a new infection. After a while, in the periphery, T
cells of either origin may create a new specific clone against the infection and
support immune memory.
How can the immune system distinguish T cells that are part of the home-
ostatic system and T cells with high affinity to a foreign peptide? Obviously,
this distinction is very important. A thymus filtered T cell that is part of the
homeostatic equilibrium can attach to specific self MHC-self peptide complexes
with a neither too strong, nor too weak, standardized affinity. When a tissue cell
is healthy, then all of its surface MHC I carries a self peptide, and in this case
all of these complexes are regularly visited by their respective specific TCR’s
that attach with standardized affinity. For brevity, thymus-standardized T cells
participating in the homeostasis are called homeostatic T cells in this paper.
On the other hand, a CD8+ T cell whose receptor has high affinity to a self
MHC I - foreign peptide complex (for brevity: an infection-specific CD8+ T
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cell) can reach an infected tissue cell only if each of the following conditions
holds:
• The infected tissue cell has not received complementary homeostatic T
cell visitors to some of its MHC I’s that present foreign peptides for a
critically long period of time. Thus this cell has become excited, and is
releasing alarm signals in the form of chemokines. This supposedly has an
effect on the behavior of any approaching T cell, signalling the presence
of a foreign entity.
• The contact between an infection-specific T cell and an infected tissue
cell takes place at an exciting MHC-foreign peptide complex, that is, at
a complex which causes the excitation of the infected cell. We suppose
that this circumstance has a biochemical influence on the behavior of both
contacting partners. It must be assumed that such a special contact does
not have a homeostatic, “soothing” effect on the infected cell, eliminating
its excitation, since in that case the cell would lose the vital information
that it is infected.
• The affinity of the receptor of an infection-specific T cell with the rele-
vant MHC-foreign peptide complex should be significantly larger than the
thymus standard intermediate affinity of the homeostatic T cells.
This way, an infection-specific cytotoxic T cell contacting an infected cell
can get the information that this attachment is not of the homeostatic kind,
but a meeting with an infected cell. As a result, it can lyse the infected cell
and can proliferate and differentiate into effector cells capable of combating the
infection. Thus, eventually an infection-specific T cell clone is created. This
process is supported by helper T cells as well: this follows from the explanation
in the next section.
But if there exists a non-thymic pathway to create a T cell clone, and so
some T cells do not undergo negative selection, they may recognize purely self
antigens, which in principle may lead to autoimmunity. However, the HRT
model is protected against such danger as described by the conditions above.
Namely, if a randomly generated CD8+ T cell that has not gone through the
thymus recognizes a self peptide-MHC complex, then this complex cannot be
in an exciting state, because each self peptide-MHC complex is regularly vis-
ited by complementary homeostatic T cells by the axioms of the HRT model.
(Remember that excitation is caused by the absence of visiting complementary
homeostatic T cells.) Thus, in general, the carrying cell is not in excited state
either and so does not secrete alarm signals. Hence the contacting CD8+ T
cell does not get the necessary biochemical signals (so to say, does not get per-
mission) to lyse the contacted cell, or to proliferate, or to differentiate into an
effector cell. So in healthy circumstances, such a dangerous T cell cannot create
a T cell clone.
To create immune memory of an infection, that is, an infection-specific T
cell clone of significant longevity, plus functionally distinguish the infection-
specific T cell repertoire from the homeostatic T cell repertoire, the following
assumptions seem essential as well:
• The thymus does not support the creation of an infection-specific T cell
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clone, nor does it maintain its existence; this clone should be kept alive in
the periphery.
• Lymph node filters, described in 2.4, do not filter out MHC I-infection-
specific peptide complexes; in contrast, they capture only MHC I-self pep-
tide complexes. So these MHC I-infection-specific peptide complexes can
be taken up by APC’s in the lymph node.
• Some of the APC’s in lymph nodes or in the periphery should be constantly
in a state of excitation, carrying exciting MHC-infection-specific peptide
complexes, to keep an infection-specific T cell clone alive. In other words,
regular stimulation from APC’s is needed – even when the infection has
been overcome – to maintain the existence of an infection-specific T cell
clone [28].
If these conditions do not hold, then the immune memory to this specific infec-
tion is lost.
4 Extension of the HRT Model to Humoral Im-
mune Reaction and Helper T Cells
A mechanism closely related to the one described above can explain the humoral
immune response as well. In a healthy individual, B cells meet only self (or other
harmless) native soluble antigens in the serum. Those B cells that can attach
to any of these self antigens present only self peptides on their surface MHC II
molecules. Similar is the case with other APC’s. Consequently, thymus selected
helper T cells can meet only self MHC II-self peptide complexes in the serum.
Since they attach with standardized medium affinity to their specific targets,
they send a signal to B cells: “everything is all right in the serum”. This is
part of the homeostatic control described above. It is important in our new
model that specific CD4+ T cell clones should exist for practically all kinds of
self MHC II-self peptide complexes normally present in any of the APC’s.
A new (e.g. bacterial) infection leads to the appearance of new native anti-
gens in the serum. The first line of defence is the innate immune system that
normally begins the fight against the new invader. Soon some of the APC’s,
in particular B cells with some affinity to the new antigens, will present new,
foreign peptides on their surface MHC II proteins. Then typically these new
complexes will not be bound by any helper T cell of the homeostatic repertoire
for a critically long time. This way the carrying B cell gets the information that
some of its surface MHC II has a peptide of an invader. This B cell gets into
an excited state and starts to release suitable alarm signals, that is, suitable
interleukins.
This signal initiates a non-specific, polyclonal activation in surrounding T
helper lymphocytes. As a response, they release interleukins, which stimulate
the excited B cells to division, hypermutation, and eventually to become plasma
cells. Clearly, this process may require several days; during this period the
innate immune system, including its APC’s that also obtain the interleukin
help, has to defend the host against the circulating infecting agents. Activated
cytotoxic T cells, in particular the ones specific to the infection, can also get
helper interleukins that support their division. Again, we emphasize that by
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HRT model Conventional
models[1, 2]
Positive selection supports
T cells
that have medium, stan-
dardized self-reactivity;
that are likely to be able
to respond to foreign pep-
tides.
The thymus selected T cell
repertoire
has a homeostatic role; does not react with self.
Primary recognition of
non-self is carried out
by the whole homeostatic
T cell repertoire in an in-
direct way;
by individual T cells in a
direct way.
Infection-specific T cells
can recognize non-self
only with the help of the
whole homeostatic T cell
repertoire;
on their own.
Infection-specific T cell
clones are created
in a non-thymic pathway
in the periphery;
in a thymic pathway.
Table 1: Comparison of the HRT and conventional models
the HRT model – unlike with conventional models – only the whole homeostatic
repertoire of CD4+ T cells can distinguish self and non-self : one cannot load
this burden on individual T cells.
This process gets more impetus when activated T cells leave lymph nodes
and appear in the humoral phase, as described in the previous section. Under
favorable circumstances, after a longer period of time, new infection-specific
helper T cell clones can arise as well, by a similar process as the one described
in the previous section for infection-specific cytotoxic T cells.
A brief comparison of the main assumptions and implications of our HRT
model and the conventional models is included in Table 1.
5 Experiments Verifying the Assumptions of the
HRT Model
The HRT model predicts that in a fetus the T cell repertoire reflects only self
antigens. That is, any T cell or TCR from such a repertoire can interact with
some self MHC-self peptide, with some medium affinity. Several experiments [29,
30, 31, 32, 33, 34] seem to support that T cells in newborns are of homeostatic
type. Also, an important experiment [35] shows the presence of lymphocyte
reaction to self antigens in patients with no autoimmune diseases. Another
experiment [36] verifies that T cells play an important role in tissue regeneration.
Recently, Wang et al.[37] generated transgenic (3KO) mice that express a
single peptide-MHC class I complex engineered as single chain trimers to demon-
strate “that positive selection of CD8+ T cells in these mice results in an MHC-
specific repertoire”. These T cells are highly MHC and peptide specific, gov-
erned by positive selection based on self-recognition. Thus, these T cells would
seem to be ideal for testing some key predictions of our model.
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6 Potential Applications Based on the HRTModel
6.1 Potential application in transplantation.
Acquired immune tolerance – an experimental manipulation by which the con-
tent of self-components is enlarged – means that the allograft is accepted with-
out immunosuppression while preserving the recipient’s protective immunity. It
represents a solution to the problems of acute and chronic rejection and the
resulting long-term reliance on toxic immunosuppressive therapies. Although
some historical clinical observations showed clues about how to induce tolerance
without the aid of immunosuppression in organ transplantation as early as the
1960s, efforts for its exploitation did not start for more than half a century[38].
One idea to achieve acquired immune tolerance that is consistent with the
HRT model is as follows. If a transplantation is escorted by a transplantation
of the donor’s lymphocytes or soluble lymphocyte receptors as well, then that
can lead to a microchimerism in the transplanted organ. The aim is that MHC
I-peptide complexes of donor tissue cells be constantly visited by the necessary
repertoire of donor TCR’s. By the HRT model, this inhibits donor tissue cells
from releasing alarm signals, so the recipient’s cytotoxic T cells will not attack
them. If donor T cells and TCR’s can be made constantly present in the re-
cipient’s neighboring lymph nodes as well, the HRT model predicts even better
results. This is due to the fact that then soluble donor MHC-peptide complexes
will be filtered out in these lymph nodes, so they cannot initiate the appearance
of activated T cells in the transplanted tissue.
In the literature, supporting evidence for this claim is growing. For example,
an important experiment[39] describes a so-called “infectious tolerance” in rat
or mouse heart, skin, or liver transplants: “Regulatory cells developing after the
spontaneous acceptance of a Lewis to DA liver transplant can serially adoptively
transfer the acceptance of a Lewis rat cardiac graft in spite of the presence of
in vitro antidonor reactivity. Both CD4+ and CD8+ populations have this
regulatory activity.” Another experiment[40] proves that recombinant TCR
ligands can be used to treat autoimmune diseases. A recent observation[41]
verifies that regulatory T cells contribute to maternal tolerance of the fetus.
These observations seem to support the hypothesis that T cell chimerism may
contribute to tolerance.
6.2 Potential application in cancer treatment.
A successful tumor cell must avoid or at least decrease the attacks of the immune
system on it[42]. One possibility is that the tumor cell avoids or significantly
decreases the presentation of antigens on its surface MHC I molecules. Another
possibility is that a cancer cell expresses only normal self-peptides on its sur-
face MHC I molecules. A third possibility is that tumor cells may extend the
homeostatic T cell repertoire by recruiting complementary T cells from naive T
cells that are constantly produced by the bone marrow (e.g. during long lasting
chemical carcinogenesis such as smoking). In such a way, a successful tumor cell
may create a tumor-specific homeostatic-like environment in its neighborhood or
in lymph nodes, similarly to the microchimerism in the case of transplantation,
described above.
It is a well-known fact that, as a result, most tumor cells have no immuno-
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genic effects. Then the HRT model implies that tumor cells are, paradoxically,
under homeostatic T cell control as well. This seems to conform with exper-
imental observations[43]. According to our HRT hypothesis, resection of the
primary tumor mass is perceived as loss of ’normal’ tissue cells. Consequently,
T cells striving to reconstitute homeostasis stimulate rather than inhibit the
growth of dormant tumor cells and avascular micrometastases. We therefore
suggested that such kick-start growths could be prevented by a recombinant
T cell receptor ligand therapy that modifies T cell behavior through a partial
activation mechanism[44].
7 Conclusions
A new, logic-based model of the fundamental operation of the T cell system has
been described above. We think that it can better explain some rather poorly
understood phenomena than conventional models. The most essential novelties
are: a more logical explanation of positive thymic selection; the assumed pres-
ence of an always ready homeostatic T cell repertoire for fast response to new
infections or mutations; indirect (negative) recognition of non-self antigens by
the whole homeostatic T cell repertoire; a non-thymic pathway to the creation
of infection-specific T cell clones; a somewhat novel explanation of transplan-
tation reaction and the suggestion of a new, non-immunosuppressive therapy;
and, finally, the suggestion of a therapy to avoid stimulation of dormant tumor
cells after the resection of the primary tumor.
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